Syncromune®
Company Details
Status: Private
Employees: 11-50
Location:
2919 east commercial boulevard, fort lauderdale, florida, united states
Type:
sample
Technology:
sample
About: Syncromune is a privately held, clinical-stage biopharmaceutical company dedicated to the development of an in situ platform therapy optimized for metastatic solid tumor cancers that aims to achieve high response rates with potentially improved survival. The company is currently developing SYNC-T, a personalized in situ therapy that combines partial tumor oncolysis and a multi-target biologic drug. The novel SYNC-T combination approach is designed to target multiple mechanisms of cancer, promoting in situ immune activation while battling immunosuppression. The goal is to activate T cells, enabling the immune system to recognize and attack cancer throughout the body. The first two candidates, SV-101 and SV-102, are currently in Phase 1 trials.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Syncromune® | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.